Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation

Neurochemistry International

Volumn 87, Issue , 2015, Pages 92-105

  Sharma, Neha ^a   Nehru, Bimla ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Lipopolysaccharide; Microglial activation; Motor dysfunction; Neuroinflammation; Oxidative stress; Parkinson's disease

Indexed keywords

CASPASE 3; CASPASE 9; CATALASE; GLUTATHIONE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; TYROSINE 3 MONOOXYGENASE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; GLIA CELL; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; LOCOMOTION; MALE; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA; WEIGHT CHANGE; ANIMAL; DISEASE MODEL; DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; LIPOPOLYSACCHARIDES; MALE; NEUROTRANSMITTER AGENTS; OXIDATIVE STRESS; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 84937643362     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2015.06.004     Document Type: Article

References (58)

1. J.K. Andersen Oxidative stress in neurodegeneration: cause or consequence? Nat. Rev. Neurosci 5 2004 S18 S25
2. M.F. Beal Mitochondria take center stage in aging and neurodegeneration Ann. Neurol 58 2005 495 505
3. T.M. Best Free radical activity, antioxidant enzyme, and glutathione changes with muscle stretch injury in rabbits J. Appl. Physiol 87 1999 74 82
4. S. Bharath Glutathione, iron and Parkinson's disease Biochem. Pharmacol 64 2002 1037 1048
5. M.L. Block, and Hong J.S. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism Prog. Neurobiol 76 2005 77 98
6. M.L. Block, L. Zecca, and Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms Nat. Rev. Neurosci 8 2007 57 69
7. C. Brown, and J.J. Neher Inflammatory neurodegeneration and mechanisms of microglial killing of neurons Mol. Neurobiol 2010 1 6
8. R.J. Carter Curr. Protoc. Neurosci 15 2001 8.12.1 8.12.14
9. A. Castaño, A.J. Herrera, J. Cano, and A. Machado Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system J. Neurochem 70 1998 1584 1592
10. A. Castaño, A.J. Herrera, J. Cano, and A. Machado The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasoneand not mimicked by rh-TNF-α IL-1β IFN-γ J. Neurochem 81 1 2002 150 157
11. W. Church Column chromatography analysis of brain tissue: an advanced laboratory exercise for neuroscience majors J. Undergrad. Neurosci. Educ 3 2005 A36 A41
12. W.D. Clapp, P.S. Thorne, K.L. Frees, Zhang X., and C.R. Lux The effects of inhalation of grain dust extract and endotoxin on upper and lower airways Chest 104 1993 825 830
13. B. Costall, and R.J. Naylor On catalepsy and catatonia and the predictability of the catalepsy test for neuroleptic activity Psychopharmacologia 1974 233 241
14. Ding Y. Impaired motor activity and motor learning function in rat with middele cerebral artery occlusion Behav. Brain Res 132 1990 29 36
15. R. Dringen Glutathione metabolism and oxidative stress in neurodegeneration Eur. J. Biochem 267 2000 4903
16. G. Dutta, Zhang P., and Liu B. The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery Fundam. Clin. Pharmacol 22 2008 453 464
17. G.L. Ellman Tissue sulphydryl groups Arch. Biochem. Biophys 82 1959 70 77
18. R.H. Garman Histology of the central nervous system Toxicol. Pathol 39 2011 22 35
19. S. Genc, Z. Zadeoglulari, S.H. Fuss, and K. Genc The adverse effects of air pollution on the nervous system J. Toxicol 2012 782462
20. C.K. Glass, K. Saijo, B. Winner, M.C. Marchetto, and F.H. Gage Mechanisms underlying inflammation in neurodegeneration Cell 140 2010 918 934
21. T. Gonzalez-Hernandez, D. Afonso-Oramas, and I. Cruz-Muros Phenotype, compartmental organization and differential vulnerability of nigral dopaminergic neurons J. Neural Transm. Suppl 2009 21 37
22. C.A. Grzegorz, C. Magdalena, M. Chalimoniuk, G. Barbara, and J.B. Strosznajde Role of nitric oxide in the brain during lipopolysaccharide-evoked systemic inflammation J. Neurosci. Res 85 2007 1694 1703
23. He Q., Yu W., Wu J., Chen C., Lou Z., Zhang Q., and et al. Intranasal LPS-mediated Parkinson's model challenges the pathogenesis of nasal cavity and environmental toxins PLoS ONE 8 2013 e78418
24. A.J. Herrera, J. Castano, L. Venero, J. Cano, and A. Machado The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system Neurobiol. Dis 7 2000 429 447
25. D.J. Hines, H.B. Choi, R.M. Hines, and A.G. Phillips Prevention of LPS-induced microglia activation, cytokine production and sickness behavior with TLR4 receptor interfering peptides PLoS ONE 8 3 2013 e60388
26. D.B. Hoban, E. Connaughton, C. Connaughton, G. Hogan, T. Chloe, P. Mulcahy, and et al. Further characterisation of the LPS model of Parkinson's disease: a comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat Brain Behav. Immun 27 2013 91 100
27. K. Hoshino, O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, and et al. Cutting edge Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product J. Immunol 162 1999 3749 3752
28. G.L. Humason Basic procedures - animal tissue technique Animal Tissue Techniques 1962 W. H. Freeman & Co. San Francisco 130 132 Part-1
29. Y. Imai, K. Venderova, D.S. Park, Cai H., and E. Schmidt Animal Models of Parkinson's Disease 2011 10.4061/2011/36432
30. M.M. Iravani, K. Kashefi, P. Mander, S. Rose, and P. Jenner Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration Neuroscience 110 2002 49 58
31. K.A. Jellinger Cell death mechanisms in Parkinson's disease J. Neural Transm 107 2000 1 29
32. H. Kalonia, J. Mishra, and A. Kumar Targeting neuro-inflammatory cytokines and oxidative stress by minocycline attenuates quinolinic-acid-induced Huntington's disease-like symptoms in rats Neurotox. Res 22 2012 310 320
33. Y. Kono Generation of superoxide radicals during auto oxidation of hydroxylamine and an assay for superoxide dismutase Arch. Biochem. Biophys 1978 186 189
34. J.B. Koprich, C. Reske-Nielsen, P. Mithal, and O. Isacson Neuroinflammation mediated by IL-1β increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease J. Neuroinflammation 5 2008 8
35. S.K. Kulkarni Handbook of Experimental Pharmacology third ed. 2002 Vallabh Prakashan Delhi
36. L.J. Lawson, V.H. Perry, P. Dri, and S. Gordon Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain Neuroscience 39 1990 151 170
37. S. Lehnardt, C. Lachance, S. Patrizi, S. Lefebvre, P.L. Follett, F.E. Jensen, and et al. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS J. Neurosci 22 2002 2478 2486
38. Lin M.T., and M.F. Beal Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases Nature 443 2006 787 795
39. Liu B., Gao H.M., and Hong J.S. Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation Environ. Health Perspect 111 2003 1065 1073
40. C.M. Long-Smith, L. Collins, A. Toulouse, A.M. Sullivan, and Y.M. Nolan Interleukin-1beta contributes to dopaminergic neuronal death induced by lipopolysaccharide-stimulated rat glia in vitro J. Neuroimmunol 226 2010 20 26
41. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Follin's phenol reagent J. Biol. Chem 193 1951 265 275
42. H. Luck H.U. Bergmeyer, Methods of enzymatic analysis 1963 Academic Press New York 885 888
43. R. Maurino, A. Machado, and M. Santiago Effect of invivo striatal perfusion of Lipopolysaccharide on dopamine metabolites Neurosci. Lett 475 2010 121 123
44. M.K. McCoy, T.N. Martinez, K.A. Ruhn, D.E. Szymkowski, C.G. Smith, and B.R. Botterman Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease J. Neurosci 226 2006 9365 9375
45. T. Nagatsu, and M. Sawada Cellular and molecular mechanisms of Parkinson's disease: neurotoxins, causative genes, and inflammatory cytokines Cell. Mol. Neurobiol 26 2006 781 802
46. B. Nehru, R. Verma, P. Khanna, and S.K. Sharma Behavioral alterations in rotenone model of parkinson's disease: attenuation by co-treatment of centrophenoxine Brain Res 1201 2008 122 127
47. C.F. Orr, D.B. Rowe, and G.M. Halliday An inflammatory review of Parkinson's disease Prog. Neurobiol 68 2002 325 340
48. M.D. Pereira, K. Ksiazek, and R. Menezes Oxidative stress in neurodegenerative diseases and ageing. oxidative medicine and longevity Oxid. Med. Cell. Longev 2012 796360 10.1155/2012/796360
49. K. Raddassi, B. Berthon, J.F. Petit, and G. Lemaire Role of calcium in the activation of mouse peritoneal macrophages: induction of NO synthase by calcium ionophores and thapsigargin Cell. Immunol 153 1994 443 455
50. P. Riederer, P. Sofic, W.D. Rrausch, B. Schmidt, and G.P. Reynolds Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains J. Neurochem 52 1989 515 520
51. J. Sian, D.T. Dexter, A.J. Lees, S. Daniel, P. Jenner, and C.D. Marsden Glutathione-related enzymes in brain in Parkinson's disease Ann. Neurol 36 1994 356 361
52. E. Sofic, K.W. Lange, K. Jellinger, and P. Reiderer Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease Neurosci. Lett 142 1992 128 130
53. K.U. Tufekci, S. Genc, and K. Genc The endotoxin-induced neuroinflammation model of Parkinson's disease Parkinsons Dis 2011 487450 10.4061/2011/487450
54. E.D. Wills Mechanism of lipid peroxide formation in animal tissue Biochem. J. 99 1966 667
55. C.C. Winterbourn, and D. Metodiewa The reaction of superoxide with reduced glutathione Arch. Biochem. Biophys 314 1994 284 290
56. Wu D.C., V. Jackson-Lewis, M. Vila, K. Tieu, P. Teismann, C. Vadseth, and et al. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson's disease Proc. Natl. Acad. Sci. U.S.A. 100 2003 6145 6150
57. S. Yagi, E. Yoshikawa, M. Futatsubashi, M. Yokokura, Y. Yoshihara, T. Torizuka, and et al. Progression from unilateral to bilateral parkinsonism in early Parkinson disease: implication of mesocortical dopamine dysfunction by PET J. Nucl. Med 51 2010 1250 1257
58. W.L. Zahler, and W.W. Cleland A specific and sensitive assay for disulphides J. Biol. Chem 243 1968 716 719